Anti-IL5 and anti-IL5R-alpha Therapy in Patients with clinically significant Bronchiectasis and an eosinophilic Endotype: a retrospective Case Series

被引：0
|
作者：
Rademacher, J. [1 ]
Konwert, S. [1 ]
Fuge, J. [1 ]
Dettmer, S. [2 ]
Welte, T. [1 ]
Ringshausen, F. C. [1 ]
机构：
[1] Hannover Med Sch, Klin Pneumol, Hannover, Germany
[2] Hannover Med Sch, Inst Radiol, Inst Diagnost & Intervent Radiol, Hannover, Germany
来源：
PNEUMOLOGIE | 2020年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
FV225
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [41] Overall response to anti-IL5/anti-IL5Rα treatment in severe asthma does not depend on initial bronchodilator responsiveness
    Mummler, C.
    Suhling, H.
    Kneidinger, N.
    Buhl, R.
    Kayser, M.
    Drick, N.
    Behr, J.
    Welte, T.
    Korn, S.
    Milger, K.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [42] Investigating the impact of Anti-IL5 therapy in eosinophilic granulomatosis with polyangiitis (EGPA): a three year longitudinal perspective
    Egan, Allyson C.
    Sivasothy, Pasupathy
    Owen, Caroline
    Burns, Stella
    Pero, Marcos Del Martinez
    Gore, Robin
    Jayne, David R. W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [43] Late Breaking Abstract - Daily physical activity in patients with severe eosinophilic asthma and the effect of anti-IL5 therapy.
    Panagiotou, Marios
    Koutsoukou, Antonia
    Koulouris, Nikolaos
    Rovina, Nikoletta
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [44] Investigating the impact of Anti-IL5 therapy in eosinophilic granulomatosis with polyangiitis (EGPA): a three year longitudinal perspective
    Egan, Allyson C.
    Sivasothy, Pasupathy
    Owen, Caroline
    Burns, Stella
    Pero, Marcos Del Martinez
    Gore, Robin
    Jayne, David R. W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I509 - I510
  • [45] Adherence to Criteria to Continue Targeted Anti-IL5 Therapy in Severe Refractory Eosinophilic Asthma at 12 Months
    McLaughlin, Patricia
    Mikulich, Olga
    Rajan, Mathew
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 : S217 - S217
  • [46] Combining Biologic Therapies Involving Anti-IgE, Anti-IL5, Anti-IL5R and Anti IL-4/IL-13: Experience from a Large Academic Health System
    Pitlick, Mitchell
    Pongdee, Thanai
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB193 - AB193
  • [47] Heterogeneous ILC responses in severe asthma patients undergoing anti-IL5/5Ra therapy
    Mincham, Kyle
    Loewentha, Lola
    Meyer, Garance
    Marfia, Martina
    Martin, Minerva Garcia
    Patel, Pujan
    Lloyd, Clare
    Snelgrove, Robert
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [48] Exploring the Effect of Anti-IL5 Therapy on Sputum Eosinophils in Children with Asthma
    Wilson, G.
    Liu, Q.
    Knight, J.
    Visness, C.
    Villarreal, M.
    Gill, M.
    Gruchalla, R. S.
    Liu, A. H.
    Kattan, M.
    Hershey, G.
    Togias, A.
    Becker, P. M.
    Altman, M. C.
    Busse, W.
    Jackson, D. J.
    Montgomery, R.
    Chupp, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [49] Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor α levels in patients with eosinophilic esophagitis
    Conus, Sebastien
    Straumann, Alex
    Simon, Hans-Uwe
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (01) : 269 - 269
  • [50] Long-Term Effectiveness of Anti-IL-4R Therapy Following Suboptimal Response to Anti-IL-5/5R Therapy in Severe Eosinophilic Asthma
    Gates, Jessica
    Hearn, Andrew
    Mason, Tom
    Fernandes, Mariana
    Green, Linda
    Thomson, Louise
    Roxas, Cris
    Lam, Jodie
    d'Ancona, Grainne
    Nanzer, Alexandra M.
    Dhariwal, Jaideep
    Jackson, David J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (07): : 1794 - 1800
12345